The Complete Beginner's Guide to Peptides: Everything You Need to Know in 2026

Educational guide for research and informational purposes only. Not medical advice.

The peptide space has grown faster than the educational infrastructure around it. Most people encounter peptides through forums, social media, or word of mouth — sources that often assume existing knowledge, skip foundational concepts, or promote specific compounds without context. This guide is the foundation: what peptides are, how they work biologically, how to think about them before choosing anything, and what responsible use actually looks like.

What Is a Peptide?

A peptide is a short chain of amino acids — the same building blocks that make up proteins. The distinction between a peptide and a protein is primarily length: peptides are generally defined as chains of 2–50 amino acids; proteins are longer. In practice, many of the compounds in this category range from 2 to 43 amino acids.

Peptides occur naturally throughout biology. Your body produces hundreds of endogenous peptides that function as hormones, neurotransmitters, immune signals, growth factors, and structural regulators. Insulin is a peptide. Oxytocin is a peptide. Growth hormone-releasing hormone (GHRH) is a peptide. The compounds discussed in research peptide protocols are either synthetic versions of naturally occurring peptides, analogs with chemical modifications that change their stability or potency, or entirely synthetic sequences designed to target specific receptors.

Why Peptides Work Differently Than Small-Molecule Drugs

Most pharmaceuticals are small organic molecules — aspirin, statins, SSRIs. They work by blocking enzymes, competing for receptor binding sites, or disrupting specific biochemical reactions. Peptides work differently: they mimic or modulate the body's own signaling molecules, often activating receptors that evolved to receive exactly these types of signals. This is why peptides generally have favorable safety profiles relative to synthetic small molecules — they're operating within pre-existing biological systems rather than introducing foreign chemical logic.

The trade-off: because peptides mimic endogenous signals, they are also subject to the same regulatory controls those signals are subject to. Overstimulating any axis — GH, IGF-1, insulin — has consequences proportional to the degree of overstimulation. This is why appropriate dosing, cycling, and monitoring matter.

The Major Categories — A Conceptual Map

Before choosing any compound, it helps to understand the functional landscape:

GLP-1 / Metabolic Peptides

Semaglutide, tirzepatide, retatrutide. These activate incretin receptors to regulate appetite, glucose metabolism, and fat storage. They create caloric deficits by reducing hunger rather than willpower. They have the most extensive human clinical trial data of any peptide category — FDA-approved agents with Phase 3 RCT evidence.

Best for: weight loss, glucose regulation, cardiovascular risk reduction

GH Secretagogues

CJC-1295, Ipamorelin, Tesamorelin, Sermorelin. These stimulate the pituitary to release growth hormone in pulsatile patterns that mimic natural physiology. They don't replace GH — they restore or amplify the body's own GH production. Downstream effects include lean mass support, fat mobilization, improved recovery, and connective tissue repair.

Best for: body composition, recovery, anti-aging GH axis optimization

Recovery and Tissue Repair Peptides

BPC-157, TB-500, GHK-Cu. These accelerate healing at the tissue level — reducing inflammation, promoting angiogenesis, stimulating collagen synthesis, and supporting nerve repair. BPC-157 is derived from a gastric protein and has demonstrated systemic effects across multiple tissue types in preclinical research.

Best for: injury recovery, athletic recovery, connective tissue health

Mitochondrial / Longevity Peptides

NAD+, MOTS-C, SS-31, Epithalon. These target the cellular machinery of aging — mitochondrial function, telomere biology, sirtuin signaling, and metabolic homeostasis. The longevity application is the longest-horizon use case in the peptide space, requiring consistent, sustained protocols rather than acute interventions.

Best for: biological aging, metabolic health, cellular energy, longevity protocols

Cognitive / Neurological Peptides

Selank, Semax, DSIP, Pinealon. These modulate neurotransmitter systems, neurotrophic factor expression, and sleep architecture. Primarily from Russian pharmacology research; some are clinically approved in Russia and Eastern Europe.

Best for: anxiety, cognitive performance, sleep quality, neuroprotection

Sexual Health Peptides

PT-141, Kisspeptin, Oxytocin. These work centrally — at the level of the hypothalamus and limbic system — to modulate desire, arousal, and bonding. PT-141 (bremelanotide) is FDA-approved for HSDD in women.

Best for: low libido, psychogenic sexual dysfunction, intimacy quality

How to Approach Your First Protocol — Decision Framework

Step 1: Define Your Primary Goal

The peptide space is large. Entering it without a clear primary goal leads to either analysis paralysis or scatter-shot experimentation. Be specific:

• Fat loss / body composition? → Start with the GLP-1 + GH Axis Stack framework
• Athletic recovery and injury? → Start with BPC-157 / TB-500
• GH axis optimization for lean mass? → CJC-1295 / Ipamorelin
• Cognitive performance and sleep? → Selank / Semax / DSIP
• Longevity / anti-aging? → Comprehensive longevity stack (longer horizon)

Step 2: Get Baseline Labs Before Starting Anything

This is not optional. Labs serve three functions:

1. Contraindication identification — some compounds are inappropriate for individuals with specific conditions (active cancer, pancreatitis history, elevated PSA, etc.)
2. Baseline establishment — without a starting point, you cannot evaluate response
3. Objective progress tracking — labs tell you whether the protocol is working as intended, independent of subjective experience

Minimum starting labs for most protocols: comprehensive metabolic panel, CBC, lipid panel, fasting glucose + HbA1c, IGF-1 (for GH-axis protocols), and relevant hormone panel depending on goals.

• Weight Loss / Metabolic Lab Panel
• Doctor's Consultation to review results and design an appropriate protocol

Step 3: Start with One Compound or One Stack, Not Everything

A common beginner mistake is running too many compounds simultaneously. When you add five things at once and something unexpected happens — whether positive or negative — you have no way to attribute the effect. Starting with a single compound or well-defined two-compound stack allows you to:

• Assess individual response and tolerability
• Identify the source of any side effects
• Build a personal response profile before adding complexity

Step 4: Use the Correct Dose, Not the Maximum Dose

More is not better in peptide pharmacology. Most compounds have a response curve with an optimal range — exceeding it produces diminishing returns and increases side effect risk. Start at the lower end of the research dosing range and titrate based on response and labs, not ambition.

Step 5: Cycle Appropriately

Most peptide protocols are designed for cyclic use rather than continuous administration. Continuous stimulation of any receptor system risks desensitization (receptor downregulation), disruption of feedback loops, or compensatory responses that blunt the intended effect. Follow established cycling protocols for each compound class.

Practical Matters — Reconstitution, Storage, and Injection

Lyophilized Peptides

Most research peptides are supplied lyophilized (freeze-dried) — a white powder in a sealed vial. They require reconstitution with bacteriostatic water (BW) before use. Bacteriostatic water contains 0.9% benzyl alcohol, which prevents bacterial contamination and allows multi-dose use of a single reconstituted vial.

See the complete Reconstitution and Injection Guide for step-by-step instructions, including how to calculate your dose volume based on reconstitution ratio.

Storage

• Unreconstituted (lyophilized): refrigerate (2–8°C / 36–46°F); keep away from light; most lyophilized peptides are stable for 12–24 months refrigerated
• Reconstituted: refrigerate; use within 21–30 days; do not freeze reconstituted solution
• During travel: short-term (24–72 hours) at room temperature is generally acceptable for most peptides; avoid extended exposure to heat or direct sunlight

Injection Basics

• Subcutaneous (SC): inject into the fatty layer beneath the skin; common sites are lower abdomen (pinch 1–2 inches of skin, inject at 45° angle), thigh, or upper arm; most research peptides use SC injection
• Intramuscular (IM): inject directly into muscle; used for some compounds (testosterone, TB-500 at higher volumes); requires longer needle and proper site identification
• Intranasal: Selank, Semax, and oxytocin are commonly administered intranasally; bypasses first-pass metabolism and provides rapid CNS access via olfactory routes
• Always use a new sterile needle for each injection; rotate injection sites to prevent lipohypertrophy

What Not to Do — Common Beginner Errors

• Skipping labs — running protocols without baseline bloodwork removes the ability to assess safety and efficacy
• Sourcing without quality verification — peptide quality varies widely; impure or incorrectly dosed compounds undermine the entire protocol and introduce safety concerns
• Ignoring diet and training — peptides amplify what you're already doing; they don't replace the fundamental inputs of resistance training, protein intake, and sleep
• Stacking too early — running 4–5 compounds in your first protocol makes it impossible to interpret results or identify problems
• Conflating research compounds with approved medications — most peptides discussed in this context are research compounds, not FDA-approved medications; they have not undergone Phase 3 clinical trials; risk-benefit assessment should reflect this
• Not cycling — treating peptide protocols like vitamins (continuous daily use without breaks) ignores the biology of receptor sensitivity and feedback dynamics

Starting Points by Goal

References

1. Fosgerau K, Hoffmann T. Peptide Therapeutics: Current Status and Future Directions. Drug Discov Today. 2015;20(1):122–128.
2. Craik DJ, Fairlie DP, Liras S, Price D. The Future of Peptide-Based Drugs. Chem Biol Drug Des. 2013;81(1):136–147.
3. Bhasin S, et al. Testosterone Therapy in Men with Hypogonadism. J Clin Endocrinol Metab. 2018.
4. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022.
5. Chang L, et al. BPC 157 and Wound Healing: A Systematic Review. J Physiol Pharmacol. 2011.

Educational Disclaimer: This content is for educational and informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before initiating any peptide protocol.

FitAF Performance — Educational content only.